T-cell prolymphocytic leukemia historical perspective: Difference between revisions
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}}{{Qurrat}}, {{MV}} | {{CMG}}; {{AE}}{{Qurrat}}, {{MV}} | ||
{{T-cell-prolymphocytic leukemia}} | {{T-cell-prolymphocytic leukemia}} | ||
==Overview== | |||
==Historical Perspective== | ==Historical Perspective== | ||
*40 years ago, in 1973, Catovsky first described four cases of T-cell prolymphocytic leukemia.<ref name="pmid4124423">{{cite journal |vauthors=Catovsky D, Galetto J, Okos A, Galton DA, Wiltshaw E, Stathopoulos G |title=Prolymphocytic leukaemia of B and T cell type |journal=Lancet |volume=2 |issue=7823 |pages=232–4 |date=August 1973 |pmid=4124423 |doi= |url=}}</ref><ref name="pmid28340878">{{cite journal |vauthors=Sud A, Dearden C |title=T-cell Prolymphocytic Leukemia |journal=Hematol. Oncol. Clin. North Am. |volume=31 |issue=2 |pages=273–283 |date=April 2017 |pmid=28340878 |doi=10.1016/j.hoc.2016.11.010 |url=}}</ref> | *40 years ago, in 1973, Catovsky first described four cases of T-cell prolymphocytic leukemia.<ref name="pmid4124423">{{cite journal |vauthors=Catovsky D, Galetto J, Okos A, Galton DA, Wiltshaw E, Stathopoulos G |title=Prolymphocytic leukaemia of B and T cell type |journal=Lancet |volume=2 |issue=7823 |pages=232–4 |date=August 1973 |pmid=4124423 |doi= |url=}}</ref><ref name="pmid28340878">{{cite journal |vauthors=Sud A, Dearden C |title=T-cell Prolymphocytic Leukemia |journal=Hematol. Oncol. Clin. North Am. |volume=31 |issue=2 |pages=273–283 |date=April 2017 |pmid=28340878 |doi=10.1016/j.hoc.2016.11.010 |url=}}</ref> |
Revision as of 15:20, 26 March 2019
T-cell prolymphocytic leukemia Microchapters |
Differentiating T-cell prolymphocytic leukemia historical perspective from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
T-cell prolymphocytic leukemia historical perspective On the Web |
American Roentgen Ray Society Images of T-cell prolymphocytic leukemia historical perspective |
FDA on T-cell prolymphocytic leukemia historical perspective |
CDC on T-cell prolymphocytic leukemia historical perspective |
T-cell prolymphocytic leukemia historical perspective in the news |
Blogs on T-cell prolymphocytic leukemia historical perspective |
Risk calculators and risk factors for T-cell prolymphocytic leukemia historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Qurrat-ul-ain Abid, M.D.[2], Maria Fernanda Villarreal, M.D. [3]
T-cell prolymphocytic leukemia Microchapters |
Differentiating T-cell Prolymphocytic Leukemia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
T-cell prolymphocytic leukemia historical perspective On the Web |
American Roentgen Ray Society Images of T-cell prolymphocytic leukemia historical perspective |
FDA on T-cell prolymphocytic leukemia historical perspective |
CDC on T-cell prolymphocytic leukemia historical perspective |
T-cell prolymphocytic leukemia historical perspective in the news |
Blogs on T-cell prolymphocytic leukemia historical perspective |
Directions to Hospitals Treating T-cell prolymphocytic leukemia |
Risk calculators and risk factors for T-cell prolymphocytic leukemia historical perspective |
Overview
Historical Perspective
- 40 years ago, in 1973, Catovsky first described four cases of T-cell prolymphocytic leukemia.[1][2]
- In 1994, Harris a pathologist from Boston and his colleagues made an effort to classify T-cell prolymphocytic leukemia.[3]
References
- ↑ Catovsky D, Galetto J, Okos A, Galton DA, Wiltshaw E, Stathopoulos G (August 1973). "Prolymphocytic leukaemia of B and T cell type". Lancet. 2 (7823): 232–4. PMID 4124423.
- ↑ Sud A, Dearden C (April 2017). "T-cell Prolymphocytic Leukemia". Hematol. Oncol. Clin. North Am. 31 (2): 273–283. doi:10.1016/j.hoc.2016.11.010. PMID 28340878.
- ↑ Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC (September 1994). "A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group". Blood. 84 (5): 1361–92. PMID 8068936.